Skip to main content

Advertisement

Log in

Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization

  • Viewpoint
  • Published:

From Nature Clinical Practice Endocrinology & Metabolism

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Delvigne A and Rozenberg S (2002) Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 8: 559–577

    Article  CAS  Google Scholar 

  2. De Leener A et al. (2006) Presence and absence of FSH receptor mutations provide some insights to spontaneous ovarian hyperstimulation physiopathology. J Clin Endocrinol Metab 91: 555–562

    Article  CAS  Google Scholar 

  3. Vasseur C et al. (2003) A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 349: 753–759

    Article  CAS  Google Scholar 

  4. Smits G et al. (2003) Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med 349: 760–766

    Article  CAS  Google Scholar 

  5. Delbaere A et al. (2004) New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome? Hum Reprod 19: 486–489

    Article  CAS  Google Scholar 

  6. Simoni M et al. (2002) Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update 8: 413–421

    Article  CAS  Google Scholar 

  7. Greb RR et al. (2005) A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 90: 4866–4872

    Article  CAS  Google Scholar 

  8. Behre HM et al. (2005) Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 15: 451–456

    Article  CAS  Google Scholar 

  9. Daelemans C et al. (2004) Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab 89: 6310–6315

    Article  CAS  Google Scholar 

  10. De Castro F et al. (2005) Pharmacogenetics of controlled ovarian hyperstimulation. Pharmacogenomics 6: 629–637

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Supported by the Interuniversity Attraction Poles of the Belgian Federal Office for Scientific, Technical and Cultural Affairs, and grants from the Fonds pour la Recherche Scientifique Médicale, the Fonds National de la Recherche Scientifique and Fondation Erasme.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gilbert Vassart.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Delbaere, A., Smits, G., Vassart, G. et al. Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization. Nat Rev Endocrinol 2, 590–591 (2006). https://doi.org/10.1038/ncpendmet0319

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0319

  • Springer Nature Limited

This article is cited by

Navigation